Vimarsana
Biggest News Aggregation in the World

Page 8 - Pharmaxis Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaxis Ltd Today - Breaking & Trending Today

Pharmaxis Ltd appoints senior global pharma executive Dr Simon Green as a non-executive director - Vimarsana News

Pharmaxis Ltd appoints senior global pharma executive Dr Simon Green as a non-executive director

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has appointed experienced senior global pharma executive Dr Simon Green to the Board of Directors as an independent...

Pipetting Solutions Streamline Drug Discovery for Inflammatory Diseases - Vimarsana News

Pipetting Solutions Streamline Drug Discovery for Inflammatory Diseases

Integra Biosciences’ electronic pipetting solutions are helping to improve the efficiency and accuracy of drug discovery at Pharmaxis Ltd. Click to read more...

Pharmaxis welcomes positive interim data for Phase 2 cancer trial - Vimarsana News

Pharmaxis welcomes positive interim data for Phase 2 cancer trial

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF)'s Gary Phillips tells Proactive they've concluded an interim analysis of data from six patients who have completed six...

Related Topics:
Gary PhillipsPharmaxis Ltd
Proactive news headlines including Antilles Gold, Arovella - Vimarsana News

Proactive news headlines including Antilles Gold, Arovella

Sydney, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has...

Pharmaxis Ltd fields promising interim data from skin scarring treatment study assessing PXS-6302 - Vimarsana News

Pharmaxis Ltd fields promising interim data from skin scarring treatment study assessing PXS-6302

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has demonstrated high levels of enzyme inhibition and changes in biomarkers implicated in skin scarring in interim data...